First Affiliated Hospital of Zhejiang University

• NCT07667517

  Phase 4, Not yet recruiting, 148 people, 25 Jun 2026

• Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

  Collaborator, Phase 4, Not yet recruiting, 1,996 people, 8 May 2026

• Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

  Collaborator, Phase 4, Not yet recruiting, 1,996 people, 8 May 2026

• NCT07550881

  Collaborator, Phase 2, Recruiting, 150 people, 24 Apr 2026

• NCT07395596

  Phase 4, Recruiting, 360 people, 9 Feb 2026

• NCT07159906

  Phase 1/2, Not yet recruiting, 62 people, 8 Sept 2025

• NCT07025174

  Phase 2, Recruiting, 60 people, 17 Jun 2025

• Transperineal Irreversible Electroporation for Benign Prostatic Hyperplasia

  Recruiting, 99 people, 10 Mar 2025

• NCT06754267

  Phase 2, Recruiting, 36 people, 31 Dec 2024

• NCT06742463

  Phase 2, Recruiting, 50 people, 19 Dec 2024

• NCT06621212

  Phase 2, Recruiting, 72 people, 1 Oct 2024

• NCT06621199

  Phase 2, Recruiting, 42 people, 1 Oct 2024

• NCT06572813

  Phase 1/2, Recruiting, 63 people, 27 Aug 2024

• NCT06554626

  Phase 2, Recruiting, 20 people, 15 Aug 2024

• NCT06520163

  Collaborator, Phase 3, Recruiting, 99 people, 25 Jul 2024

• NCT06520176

  Collaborator, Phase 3, Recruiting, 99 people, 25 Jul 2024

• NCT06434662

  Phase 2, Status unknown, 34 people, 30 May 2024

• NCT06361329

  Phase 3, Recruiting, 81 people, 11 Apr 2024

• NCT06118034

  Collaborator, Phase 3, Recruiting, 768 people, 7 Nov 2023

• NCT06078969

  Collaborator, Phase 2, Recruiting, 118 people, 12 Oct 2023

Sources: clinicaltrials.gov